Form 4: Natera Co-Founder Sells Shares, Receives RSUs

Natera's Co-Founder and Director, Jonathan Sheena, reported the acquisition of Restricted Stock Units and subsequent sales of common stock under a pre-arranged trading plan.

Summary

• Jonathan Sheena, a Director and Co-Founder of Natera, Inc. (NTRA), acquired 2,103 shares of common stock on February 27, 2026, representing Restricted Stock Units (RSUs).
• These RSUs will vest over four years, with 25% vesting on March 1, 2027, and the remainder in 12 equal quarterly installments thereafter.
• On March 2, 2026, Sheena sold a total of 3,070 shares of Natera common stock.
• The sales were executed at weighted average prices ranging from $198.4956 to $202.85 per share.
• All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on June 7, 2024.
• Following these transactions, Sheena directly beneficially owns 262,194 shares of common stock.
• Additionally, 21,782 shares are held indirectly by Caraluna 1 Trust and 21,782 shares by Caraluna 2 Trust, over which Sheena disclaims beneficial ownership.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While there are insider sales, they are pre-planned, and the RSU grant represents a positive long-term incentive for a key co-founder and director.

Positives

• Jonathan Sheena, a Co-Founder and Director, received an issuance of 2,103 Restricted Stock Units (RSUs), aligning his interests with long-term company performance.
• The RSUs have a vesting schedule over four years, indicating a commitment to the company's future.

Negatives

• Jonathan Sheena sold a total of 3,070 shares of common stock on March 2, 2026, at prices ranging from $198.4956 to $202.85.
• While these sales were pre-planned under a Rule 10b5-1 plan, they represent a reduction in direct beneficial ownership by a key insider.

Future Outlook

The acquired Restricted Stock Units (RSUs) for Jonathan Sheena are scheduled to vest over four years, with the first 25% vesting on March 1, 2027, and the remainder in 12 equal quarterly installments thereafter, indicating a long-term incentive structure.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are common for executives managing personal finances or diversifying portfolios, especially when executed under a Rule 10b5-1 plan. The grant of RSUs is a standard compensation practice to align executive incentives with shareholder value over the long term.

Stakeholder Impact

• Shareholders: The sale of shares by a co-founder could be perceived negatively by some, but the pre-planned nature mitigates concerns. The RSU grant aligns insider interests with long-term shareholder value.

Next Steps

• The remaining 75% of the acquired RSUs will vest in 12 equal quarterly installments after March 1, 2027.

Key Dates

Recommendation

The filing details routine insider transactions, including both the acquisition of Restricted Stock Units (RSUs) as part of compensation and the sale of shares under a pre-arranged 10b5-1 trading plan. These actions are generally expected and do not provide new fundamental information to warrant a change in investment thesis. The RSU grant is a positive for long-term alignment, while the sales are pre-scheduled and not indicative of a change in management's outlook. Therefore, a 'hold' recommendation is appropriate as the filing does not present a compelling reason to buy or sell based solely on this information.

Keywords

Natera, NTRA, Jonathan Sheena, Insider Trading, Form 4, Restricted Stock Units, RSU, Stock Sale, Beneficial Ownership, Rule 10b5-1, Director Transaction, Co-Founder